Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To evaluate the overall response rate [ie, proportion of subjects with complete response (CR) and partial response (PR)] to treatment with Prolarix at the MTD determined in a previous Phase 1 study (26.6 mg/m2 tretazicar co-administered with 200 mg/m2 caricotamide).
Inclusion criteria
- Hepatocellular carcinoma (HCC)